Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 20;24(10):677-682.
doi: 10.3779/j.issn.1009-3419.2021.101.35.

[Radiofrequency Ablation for Lung Ground-glass Nodule]

[Article in Chinese]
Affiliations

[Radiofrequency Ablation for Lung Ground-glass Nodule]

[Article in Chinese]
Xiaogang Tan et al. Zhongguo Fei Ai Za Zhi. .

Abstract

Background: With the wide application of computed tomography (CT) in the screening of early lung cancer, more and more ground glass nodules (GGNs) have been found. Early intervention is helpful to improve the survival rate of lung cancer patients. Radiofrequency ablation (RFA) is an alternative option to manage primary or metastatic lung malignancies. The purpose of this study is to review the safety and clinical efficacy for lung GGN treated by RFA.

Methods: From June 2016 to March 2021, 24 patients with a total of 28 lung GGNs in our hospital underwent 28 sessions of RFA. There were 13 males and 11 females with an average age of (69.4±11.1) years. The size of GGN receiving RFA was (1.30±0.56) cm; The ablation range was (2.50±0.63) cm and ablation time was (15.00±8.68) min.

Results: The procedure of all RFAs went smoothly, no perioperative deaths occurred and no serious complications during the operation. The median follow-up was 25 months. One case died of myocardial infarction 2 months after operation. All 28 GGNs showed no evidence of local progression and the local control rate was 100.0%. Kaplan-Meier analysis showed that the 1-year and 2-year overall survival rates were 95.8% and 95.8%; the tumor specific survival rates were 100.0% and 100.0%, respectively.

Conclusions: RFA is a safe, effective and minimally invasive technique for the treatment of lung GGNs.

【中文题目:射频消融治疗肺磨玻璃结节的临床价值】 【中文摘要:背景与目的 随着计算机断层扫描(computed tomography, CT)广泛应用于肺癌筛查,越来越多的肺磨玻璃结节(ground-glass nodule, GGN)被发现,尽早干预有利于提高肺癌患者的生存率。射频消融(radiofrequency ablation, RFA)是治疗原发性或转移性肺部恶性肿瘤的一种替代方法。本研究旨在探讨RFA治疗肺GGN的安全性和临床疗效。方法 选择我院2016年6月-2021年3月收治的24例肺GGN患者,共计28枚结节,接受RFA治疗,其中男性13例,女性11例,平均年龄为(69.4±11.1)岁。接受RFA的GGN大小为(1.30±0.56)cm;消融范围为(2.50±0.63)cm;消融时间为(15.00±8.68)min。结果 全部结节手术顺利,所有患者无围术期死亡,术中无严重并发症发生。中位随访时间为25个月。1例术后2个月因心梗去世。28个结节均无局部进展,局部控制率为100.0%。Kaplan-Meier分析患者1年、2年的总体生存率分别为95.8%、95.8%;肿瘤特异生存率分别为100.0%、100.0%。结论 RFA是治疗肺GGN安全有效的微创技术。 】 【中文关键词:射频消融;肺磨玻璃结节;临床疗效】.

Keywords: Clinical effective; Lung ground-glass nodule; Radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

Competing interests】The authors declare that they have no competing interests.

Figures

1
1
78岁女性,CT发现右肺上叶GGN,组织学病理证实为腺癌。A:射频消融前的CT图像显示右上肺有一个直径2.0 cm的GGN;B:CT透视RFA过程中的图像显示电极被插入GGN;射频消融后10.2个月(C)和26.5个月(D)的CT图像显示消融肿瘤消退,表明完全消融。 Right upper lobe GGN was detected on CT in an 78-year-old woman, histologically confirmed as adenocarcinoma. A: CT image before RFA in the lung window setting shows a tumor, 2.0 cm in diameter, located in the right upper lobe; B: CT images shows that a electrode is introduced into the tumor; 10.2 months (C) and 26.5 months (D) after RFA in the lung window setting shows that the tumor was well controled. CT: computed tomography; RFA: radiofrequency ablation.
2
2
消融前后GGN的CT影像变化。A:消融前GGN;B:消融后肿瘤周围出现GGO,CT上靶区轮廓变得不清晰。 Comparison of CT images of GGNs before and after RFA. A: The image of GGN before RFA was performed; B: The tumor was covered by the GGO after RFA, and the contour of the target area becomes unclear on CT. GGO: ground-glass opacity.

Similar articles

Cited by

References

    1. Latest global cancer data: Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020. Retrieved Nov 16, 2020, from https://www.iarc.fr/fr/news-events/latest-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020/

    1. Zheng RS, Sun KX, Zhang SW, et al. Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi. 2019;41(1):19–28. - PubMed
    2. 郑 荣寿, 孙 可欣, 张 思维, et al. 2015年中国恶性肿瘤流行情况分析. 中华肿瘤杂志. 2019;41(1):19–28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005. - DOI - PubMed
    1. Burdett S, Stewart L, Auperin A, et al. Chemotherapy in non-small-cell lung cancer: an update of an individual patient data meta-analysis. J Clin Oncol. 2005;23(4):924–925. doi: 10.1200/JCO.2005.05.303. - DOI - PubMed
    1. Betticher DC, Hsu Schmitz SF, Tötsch M, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage Ⅲa pN2 non-small-cell lung cancer: a multicenter phase Ⅱ trial. J Clin Oncol. 2003;21(9):1752–1759. doi: 10.1200/JCO.2003.11.040. - DOI - PubMed
    1. NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383(9928):1561–1571. doi: 10.1016/S0140-6736(13)62159-5. - DOI - PMC - PubMed